Literature DB >> 28351907

Frequency, Predictors, and Implications of Abnormal Blood Pressure Responses During Dobutamine Stress Echocardiography.

Sara Abram1, Adelaide M Arruda-Olson1, Christopher G Scott1, Patricia A Pellikka1, Vuyisile T Nkomo1, Jae K Oh1, Alberto Milan1, Mohamed M Abidian1, Robert B McCully2.   

Abstract

BACKGROUND: It is not known whether abnormal blood pressure (BP) responses during dobutamine stress echocardiography (DSE) are associated with abnormal test results, nor if such results indicate obstructive coronary artery disease (CAD). We sought to define the frequency of abnormal BP responses during DSE and their impact on accuracy of test results. METHODS AND
RESULTS: We studied 21 949 patients who underwent DSE at Mayo Clinic, Rochester, MN, grouped by peak systolic BP achieved during the test. We also analyzed a subgroup who underwent coronary angiography within 30 days after positive DSE. The positive predictive value of DSE was calculated for each BP group. Patients with hypertensive response (n=1905; 9%) were more likely to have positive DSE than those with normal (n=19 770; 90%) or hypotensive (n=274; 1%) BP responses (32% versus 21% versus 23%, respectively; P<0.0001). Angiography, performed in 1126 patients, showed obstructive CAD (≥50% stenosis) in 814 patients and severe CAD (≥70% stenosis) in 708 patients. Positive predictive value of DSE was similar for patients who had hypertensive and normal BP responses (69% versus 73%; P=0.3), considering 50% stenosis cut point. The proportion of severe CAD (≥70% stenosis) was lower in patients who had hypertensive response compared with those who had normal BP response (54% versus 65%; P=0.005).
CONCLUSIONS: Patients with hypertensive response during DSE are more likely to have stress-induced myocardial ischemia compared with those with normal or hypotensive BP responses but are not more likely to have false-positive DSE results. They are, however, less likely to have higher grade or multivessel CAD.
© 2017 American Heart Association, Inc.

Entities:  

Keywords:  blood pressure; coronary angiography; coronary artery disease; dobutamine; echocardiography

Mesh:

Substances:

Year:  2017        PMID: 28351907      PMCID: PMC5408460          DOI: 10.1161/CIRCIMAGING.116.005444

Source DB:  PubMed          Journal:  Circ Cardiovasc Imaging        ISSN: 1941-9651            Impact factor:   7.792


  27 in total

Review 1.  Expert consensus document on beta-adrenergic receptor blockers.

Authors:  José López-Sendón; Karl Swedberg; John McMurray; Juan Tamargo; Aldo P Maggioni; Henry Dargie; Michal Tendera; Finn Waagstein; Jan Kjekshus; Philippe Lechat; Christian Torp-Pedersen
Journal:  Eur Heart J       Date:  2004-08       Impact factor: 29.983

2.  Expert consensus document on arterial stiffness: methodological issues and clinical applications.

Authors:  Stephane Laurent; John Cockcroft; Luc Van Bortel; Pierre Boutouyrie; Cristina Giannattasio; Daniel Hayoz; Bruno Pannier; Charalambos Vlachopoulos; Ian Wilkinson; Harry Struijker-Boudier
Journal:  Eur Heart J       Date:  2006-09-25       Impact factor: 29.983

3.  2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology.

Authors:  Gilles Montalescot; Udo Sechtem; Stephan Achenbach; Felicita Andreotti; Chris Arden; Andrzej Budaj; Raffaele Bugiardini; Filippo Crea; Thomas Cuisset; Carlo Di Mario; J Rafael Ferreira; Bernard J Gersh; Anselm K Gitt; Jean-Sebastien Hulot; Nikolaus Marx; Lionel H Opie; Matthias Pfisterer; Eva Prescott; Frank Ruschitzka; Manel Sabaté; Roxy Senior; David Paul Taggart; Ernst E van der Wall; Christiaan J M Vrints; Jose Luis Zamorano; Stephan Achenbach; Helmut Baumgartner; Jeroen J Bax; Héctor Bueno; Veronica Dean; Christi Deaton; Cetin Erol; Robert Fagard; Roberto Ferrari; David Hasdai; Arno W Hoes; Paulus Kirchhof; Juhani Knuuti; Philippe Kolh; Patrizio Lancellotti; Ales Linhart; Petros Nihoyannopoulos; Massimo F Piepoli; Piotr Ponikowski; Per Anton Sirnes; Juan Luis Tamargo; Michal Tendera; Adam Torbicki; William Wijns; Stephan Windecker; Juhani Knuuti; Marco Valgimigli; Héctor Bueno; Marc J Claeys; Norbert Donner-Banzhoff; Cetin Erol; Herbert Frank; Christian Funck-Brentano; Oliver Gaemperli; José R Gonzalez-Juanatey; Michalis Hamilos; David Hasdai; Steen Husted; Stefan K James; Kari Kervinen; Philippe Kolh; Steen Dalby Kristensen; Patrizio Lancellotti; Aldo Pietro Maggioni; Massimo F Piepoli; Axel R Pries; Francesco Romeo; Lars Rydén; Maarten L Simoons; Per Anton Sirnes; Ph Gabriel Steg; Adam Timmis; William Wijns; Stephan Windecker; Aylin Yildirir; Jose Luis Zamorano
Journal:  Eur Heart J       Date:  2013-08-30       Impact factor: 29.983

4.  Atropine augmentation in dobutamine stress echocardiography: role and incremental value in a clinical practice setting.

Authors:  L H Ling; P A Pellikka; D W Mahoney; J K Oh; R B McCully; V L Roger; J B Seward
Journal:  J Am Coll Cardiol       Date:  1996-09       Impact factor: 24.094

5.  A new, simplified and accurate method for determining ejection fraction with two-dimensional echocardiography.

Authors:  M A Quinones; A D Waggoner; L A Reduto; J G Nelson; J B Young; W L Winters; L G Ribeiro; R R Miller
Journal:  Circulation       Date:  1981-10       Impact factor: 29.690

6.  Typical blood pressure response during dobutamine stress echocardiography of patients without known cardiovascular disease who have normal stress echocardiograms.

Authors:  Sara Abram; Adelaide M Arruda-Olson; Christopher G Scott; Patricia A Pellikka; Vuyisile T Nkomo; Jae K Oh; Alberto Milan; Robert B McCully
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2015-07-22       Impact factor: 6.875

7.  False-positive exercise echocardiograms: impact of sex and blood pressure response.

Authors:  Joon-Han Shin; Takahiro Shiota; Yong-Jin Kim; Jun Kwan; Jian Xin Qin; Yoko Eto; L Leonardo Rodriguez; James D Thomas
Journal:  Am Heart J       Date:  2003-11       Impact factor: 4.749

8.  Does hypotension during dobutamine stress echocardiography correlate with anatomic or functional cardiac impairment?

Authors:  E B Lieberman; S K Heinle; N Wildermann; R A Waugh; J A Kisslo; T M Bashore
Journal:  Am Heart J       Date:  1995-06       Impact factor: 4.749

9.  Hypotension during dobutamine stress echocardiography: initial description and clinical relevance.

Authors:  T L Rosamond; J L Vacek; A Hurwitz; A J Rowland; G D Beauchamp; L J Crouse
Journal:  Am Heart J       Date:  1992-02       Impact factor: 4.749

10.  An exaggerated blood pressure response to treadmill exercise does not increase the likelihood that exercise echocardiograms are abnormal in men or women.

Authors:  Traci L Jurrens; Aaron M From; Garvan C Kane; Sharon L Mulvagh; Patricia A Pellikka; Robert B McCully
Journal:  J Am Soc Echocardiogr       Date:  2012-08-01       Impact factor: 5.251

View more
  3 in total

1.  LncRNA SNHG8 is identified as a key regulator of acute myocardial infarction by RNA-seq analysis.

Authors:  Liu-An Zhuo; Yi-Tao Wen; Yong Wang; Zhi-Fang Liang; Gang Wu; Mei-Dan Nong; Liu Miao
Journal:  Lipids Health Dis       Date:  2019-11-18       Impact factor: 3.876

2.  Test-Retest Reliability of the Coronary Heart Disease Damp Phlegm and Blood Stasis Pattern Questionnaire: Results from a Multicenter Clinical Trial.

Authors:  Ge Fang; Yaxin Wang; Zhenqian Yan; Xiaowen Zhou; Xingyu Fan; Xiaoqian Liao; Zhixi Hu; Xiantao Li
Journal:  Evid Based Complement Alternat Med       Date:  2021-11-16       Impact factor: 2.629

3.  A novel circRNA-miRNA-mRNA network identifies circ-YOD1 as a biomarker for coronary artery disease.

Authors:  Liu Miao; Rui-Xing Yin; Qing-Hui Zhang; Pei-Juan Liao; Yong Wang; Rong-Jun Nie; Hui Li
Journal:  Sci Rep       Date:  2019-12-04       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.